Psychedelics are having a moment. After decades of prohibition and vilification, they are increasingly being employed as therapeutics. Drugs like ketamine, MDMA, and psilocybin mushrooms are being studied in clinical trials to... Read more »

“We started our company knowing that women over 40 are prescribed antidepressants at more than three to four times the rate of men, which has led to one in every five women... Read more »

We all want to be able to speak our minds online—to be heard by our friends and talk (back) to our opponents. At the same time, we don’t want to be exposed... Read more »

Moderation (whether automated or human) can potentially work for what we call “acute” harms: those caused directly by individual pieces of content. But we need this new approach because there are also... Read more »

Throughout the day, Wedd­ington and her staff “pumped reporters for information,” she later wrote in her 2013 book A Question of Choice. She found a lawyer friend who could go to the... Read more »

The news: China’s chipmaking industry has descended into chaos, with at least four top executives associated with a state-owned semiconductor fund recently arrested on corruption charges. It’s an explosive turn of events... Read more »

As we inched nearer, I worried about infringing upon the other participants’ personal space. Then I remembered that oceans and thousands of miles separated me from them—and wasn’t ditching the notion of... Read more »

It remains unclear whether the failure of Unigroup directly triggered the anticorruption earthquake within Big Fund. However, the strategy that the latter has taken—throwing massive investments against the wall and seeing what... Read more »

In a search for novel forms of longevity medicine, a biotech company based in Israel says it intends to create embryo-stage versions of people in order to harvest tissues for use in... Read more »